CONNECT WITH US
HealthTech

HealthTech

Formation Bio unveils $600M fund tied to existing model

Endpoints News logo

Published on

Add as a preferred source on Google
Formation Bio unveils $600M fund tied to existing model

For­ma­tion Bio, an AI-fo­cused biotech that ac­quires out­side as­sets, de­vel­ops them and then hands them off, has raised a $600 mil­lion in­vest­ment found to dou­ble …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Astel­las nabs op­tion on pre­clin­i­cal IL-12 can­cer drug from Aus­tralian biotech October 28, 2026

Trea­sury's COINS rule draft would nar­row the path for Chi­na biotech deal­mak­ing, ex­perts say October 27, 2026

Cit­ing 'safe­ty' and 'free­dom,' HHS will al­low com­pound­ing of cer­tain well­ness pep­tides

An­throp­ic's lat­est biotech buy is a one-man stealth start­up run by a pseu­do­ny­mous Twit­ter poster

Now 78% of sci­en­tists say AI will speed drug dis­cov­ery this year: Sig­nal Sur­vey



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.